SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 44.51 |
| Enterprise Value ($M) | 37.19 |
| Book Value ($M) | 85.08 |
| Book Value / Share | 1.97 |
| Price / Book | 0.52 |
| NCAV ($M) | -5.38 |
| NCAV / Share | -0.12 |
| Price / NCAV | -8.28 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.32 |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | -0.35 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.09 |
| Current Ratio | 8.09 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 77.44 |
| Assets | 167.90 |
| Liabilities | 82.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -24.64 |
| Net Income | -31.39 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -18.29 |
| Cash from Investing | -5.76 |
| Cash from Financing | 0.14 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Tang Capital Partners Lp | 7.50 | -11.05 | |
| 13G | Sofinnova Partners SAS | 5.10 | ||
| 13G/A | BML Investment Partners, L.P. | 0.00 | -100.00 | |
| 13G | Genextra S.p.A. | 5.89 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 37,265 | 118,839 | 31.36 | |
| 28,951 | 11,655 | 248.40 | |
| 26,259 | 23,645 | 111.06 | |
| 38,486 | 30,336 | 126.87 | |
| 12,497 | 12,683 | 98.53 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PTCT – PTC Therapeutics, Inc. | PYXS – Pyxis Oncology, Inc. |
| QDEL – QuidelOrtho Corporation | QURE – uniQure N.V. |
| RARE – Ultragenyx Pharmaceutical Inc. |
Financial data and stock pages provided by
Fintel.io